ReviewFrontiers in medicine2025
Application status and research progress of targeted therapy drugs for hormone receptor-positive breast cancer.
Han Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it